Because the extent and distribution of these features differs widely between animal models, and the SMN-expression threshold below which tissue and species’ dysfunction manifests is unknown, the relevance of these extra-neuronal features to humans with SMA is uncertain. Here, SMN1 is linked to proximal spinal muscular atrophy.